There are three OCTs, two of which (OCT1 and OCT3) are predominantly expressed on endometrial cancer cells; whereas, OCT2 is predominantly expressed in kidney and is responsible for metformin clearance in urine (29). This evidence concerns the gene SLC22A3 and endometrial cancer.